The Latest Breaking News from CVS Health

CVS Health came up short of Q1 earnings estimates and slashed its full-year outlook as medical costs surged. Here's what you need to know.

CVS Health earnings tumbled more than expected on a surge in Medicare costs due to higher utilization. CVS stock dived, weighing on UNH and HUM.

The largest U.S. drugstore chain, CVS Health (CVS), will release its fourth-quarter results on February 7. The company is expected to report year-over-year growth in revenue and earnings. With the expected rise in medical costs during the fourth quarter, should investors consider buying the stock now? Read on to learn…

The health insurer says 2024 earnings will be barely half of estimates due to higher Medicare Advantage costs.

CVS loyalty program members will now have two tiers of 'ExtraCare' benefits to choose from.

Enrollment in Medicare Advantage plans has outpaced expectations, but people should use caution when viewing these plans, expert says.

Looking ahead, 2024 likely will be filled with volatility, uncertainty, complexity, and ambiguity. That’s "VUCA" for you.

Three major pharmacy chains admitted to encouraging staff to hand prescription records over to law enforcement without a warrant, and without a legal review.

CVS Health is introducing changes to how its prescription drug pricing model works, and that could lead to some savings for customers starting next year